News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011

BOULDER, Colo., Oct 24, 2011 (BUSINESS WIRE) --

Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the first quarter of fiscal 2012 on Monday, October 31, 2011, and will hold a conference call on Tuesday, November 1, 2011 at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information

Date:

Tuesday, November 1, 2011

Time:

9:00 a.m. eastern time

Toll-Free:

800.260.8140

Toll:

617.614.3672

Pass Code:

85947414

Webcast & Conference Call Slides:

http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome

A replay of the call will be available as a webcast on www.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com